PHILADELPHIA — OCT. 27-30, 2010
FOLLOW US ON TWITTER: @AACR #AACR
What:
Colorectal cancer is the second leading cause of cancer deaths in the United States, with an estimated 51,370 deaths expected this year alone.
This October, the American Association for Cancer Research will host the special conference Colorectal Cancer: Biology to Therapy at the Loews Philadelphia Hotel. Hundreds of scientists, physicians and allied health professionals will gather and discuss new data on new screening methods and emerging therapies.
Findings presented at this year’s meeting will include:
• validation studies of new genetics-based screening methods;
• how scientists are targeting stem cells as a therapeutic option;
• the role of inflammation in colorectal cancer;
• new colon cancer inhibitors in development; and
• earlier detection methods that will prevent mortality.
To help you plan your coverage of the conference, the program schedule is available online at www.aacr.org/colorectalprogram. An electronic press kit containing the press releases and selected highlighted abstracts will be available on Oct. 20 via EurekAlert, Newswise and to members of the media registered through the AACR Communications Department.
When:
Oct. 27-30, 2010
Where:
Loews Philadelphia Hotel
Philadelphia, Pa.
Contact/Press Registration:
Natalie Poole
(267) 646-0619 / natalie.poole@aacr.org
Registration: www.aacr.org/page22756.aspx
# # #
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 32,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists, providing a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.
